سوق الأدوية الجنيسة

Language of the Report - English

ومع ذلك، قد يكون التقرير متوفرًا بالعربية مقابل تكلفة إضافية.

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Generic Drugs Industry
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Country
    5.5    Market Breakup by Therapy Area
    5.6    Market Breakup by Drug Delivery
    5.7    Market Breakup by Distribution Channel
    5.8    Market Forecast 
    5.9    SWOT Analysis
        5.9.1 Overview
        5.9.2 Strengths
        5.9.3 Weaknesses
        5.9.4 Opportunities
        5.9.5 Threats
    5.10    Value Chain Analysis
        5.10.1 Research and Development
        5.10.2 Manufacturing
        5.10.3 Marketing and Distribution
    5.11    Porter’s Five Forces Analysis
        5.11.1 Overview
        5.11.2 Bargaining Power of Buyers
        5.11.3 Bargaining Power of Suppliers
        5.11.4 Degree of Competition
        5.11.5 Threat of New Entrants
        5.11.6 Threat of Substitutes
    5.12    Regulations in the Generic Industry
    5.13    Key Market Drivers and Success Factors
6   Performance of Key Countries
    6.1    United States
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    China
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Brazil
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Germany
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    France
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    India
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    United Kingdom
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Japan
        6.8.1 Market Trends
        6.8.2 Market Forecast
    6.9    Canada
        6.9.1 Market Trends
        6.9.2 Market Forecast
    6.10    Italy
        6.10.1 Market Trends
        6.10.2 Market Forecast
    6.11    Others
        6.11.1 Market Trends
        6.11.2 Market Forecast
7   Market Breakup by Therapy Area
    7.1    Central Nervous System
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cardiovascular
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Dermatology
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Genitourinary/Hormonal
        7.4.1 Market Trends
        7.4.2 Market Forecast 
    7.5    Respiratory
        7.5.1 Market Trends
        7.5.2 Market Forecast 
    7.6    Rheumatology 
        7.6.1 Market Trends
        7.6.2 Market Forecast 
    7.7    Diabetes
        7.7.1 Market Trends
        7.7.2 Market Forecast
    7.8    Oncology
        7.8.1 Market Trends
        7.8.2 Market Forecast
    7.9    Others
        7.9.1 Market Trends
        7.9.2 Market Forecast
8   Market Breakup by Drug Delivery
    8.1    Oral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Injectables
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Dermal/Topical
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Inhalers
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Hospital Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
10  Competitive Landscape
    10.1    Market Structure
    10.2    Market Breakup by Key Players
    10.3    Key Player Profiles
        10.3.1 Teva Pharmaceuticals Industries Ltd.
        10.3.2 Mylan N.V.
        10.3.3 Novartis AG
        10.3.4 Pfizer Inc.
        10.3.5 Sun Pharmaceutical Industries Ltd.
        10.3.6 Fresenius SE & Co.
        10.3.7 Lupin Limited
        10.3.8 Endo Pharmaceuticals Inc.
        10.3.9 Aurobindo Pharma Limited
        10.3.10 Aspen Pharmacare Holdings Limited
11  Generic Drugs Manufacturing Process
    11.1    Product Overview
    11.2    Detailed Process Flow (Tablets)
    11.3    Detailed Process Flow (Injectable)
    11.4    Various Types of Unit Operations Involved
    11.5    Mass Balance and Raw Material Requirements
12  Project Details, Requirements and Costs Involved
    12.1    Land Requirements and Expenditures
    12.2    Construction Requirements and Expenditures
    12.3    Plant Machinery
    12.4    Machinery Pictures
    12.5    Raw Material Requirements and Expenditures
    12.6    Packaging Requirements and Expenditures
    12.7    Transportation Requirements and Expenditures
    12.8    Utility Requirements and Expenditures
    12.9    Manpower Requirements and Expenditures
    12.10    Other Capital Investments
13  Loans and Financial Assistance
14  Project Economics
    14.1    Capital Cost of the Project
    14.2    Techno-Economic Parameters
    14.3    Product Pricing and Margins Across Various Levels of the Supply Chain
    14.4    Taxation and Depreciation
    14.5    Income Projections
    14.6    Expenditure Projections
    14.7    Financial Analysis
    14.8    Profit Analysis

List of Figure

Figure 1: Global: Generic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Generic Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Generic Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Generic Drugs Market: Breakup by Country (in %), 2022
Figure 5: Global: Generic Drugs Market: Breakup by Therapy Area (in %), 2022
Figure 6: Global: Generic Drugs Market: Breakup by Drug Delivery (in %), 2022
Figure 7: Global: Generic Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Generic Drugs Industry: SWOT Analysis
Figure 9: Global: Generic Drugs Industry: Value Chain Analysis
Figure 10: Global: Generic Drugs Industry: Porter’s Five Forces Analysis
Figure 11: USA: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 12: USA: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 13: China: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 14: China: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 15: Brazil: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 16: Brazil: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 17: Germany: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 18: Germany: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 19: France: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 20: France: Generic Drugs Market Forecast (in Million US$), 2023-2028 
Figure 21: India: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 22: India: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 23: United Kingdom: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 24: United Kingdom: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 25: Japan: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 26: Japan: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 27: Canada: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 28: Canada: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 29: Italy: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 30: Italy: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 31: Others: Generic Drugs Market (in Million US$), 2017 & 2022
Figure 32: Others: Generic Drugs Market Forecast (in Million US$), 2023-2028
Figure 33: Global: Generic Drugs Market: Oral (in Million US$), 2017 & 2022
Figure 34: Global: Generic Drugs Market Forecast: Oral (in Million US$), 2023-2028
Figure 35: Global: Generic Drugs Market: Injectables (in Million US$), 2017 & 2022
Figure 36: Global: Generic Drugs Market Forecast: Injectables (in Million US$), 2023-2028
Figure 37: Global: Generic Drugs Market: Dermal/Topical (in Million US$), 2017 & 2022
Figure 38: Global: Generic Drugs Market Forecast: Dermal/Topical (in Million US$), 2023-2028
Figure 39: Global: Generic Drugs Market: Inhalers (in Million US$), 2017 & 2022
Figure 40: Global: Generic Drugs Market Forecast: Inhalers (in Million US$), 2023-2028
Figure 41: Global: Generic Drugs Market: Central Nervous System (in Million US$), 2017 & 2022
Figure 42: Global: Generic Drugs Market Forecast: Central Nervous System (in Million US$), 2023-2028
Figure 43: Global: Generic Drugs Market: Cardiovascular (in Million US$), 2017 & 2022
Figure 44: Global: Generic Drugs Market Forecast: Cardiovascular (in Million US$), 2023-2028
Figure 45: Global: Generic Drugs Market: Dermatology (in Million US$), 2017 & 2022
Figure 46: Global: Generic Drugs Market Forecast: Dermatology (in Million US$), 2023-2028
Figure 47: Global: Generic Drugs Market: Genitourinary/Hormonal (in Million US$), 2017 & 2022
Figure 48: Global: Generic Drugs Market Forecast: Genitourinary/Hormonal (in Million US$), 2023-2028
Figure 49: Global: Generic Drugs Market: Respiratory (in Million US$), 2017 & 2022
Figure 50: Global: Generic Drugs Market Forecast: Respiratory (in Million US$), 2023-2028
Figure 51: Global: Generic Drugs Market: Rheumatology (in Million US$), 2017 & 2022
Figure 52: Global: Generic Drugs Market Forecast: Rheumatology (in Million US$), 2023-2028
Figure 53: Global: Generic Drugs Market: Diabetes (in Million US$), 2017 & 2022
Figure 54: Global: Generic Drugs Market Forecast: Diabetes (in Million US$), 2023-2028
Figure 55: Global: Generic Drugs Market: Oncology (in Million US$), 2017 & 2022
Figure 56: Global: Generic Drugs Market Forecast: Oncology (in Million US$), 2023-2028
Figure 57: Global: Generic Drugs Market: Other Therapy Areas (in Million US$), 2017 & 2022
Figure 58: Global: Generic Drugs Market Forecast: Other Therapy Areas (in Million US$), 2023-2028
Figure 59: Global: Generic Drugs Market: Retail Pharmacies (in Million US$), 2017 & 2022
Figure 60: Global: Generic Drugs Market Forecast: Retail Pharmacies (in Million US$), 2023-2028
Figure 61: Global: Generic Drugs Market: Hospital Pharmacies (in Million US$), 2017 & 2022
Figure 62: Global: Generic Drugs Market Forecast: Hospital Pharmacies (in Million US$), 2023-2028
Figure 63: Generic Drugs Industry: Profit Margins at Various Levels of the Supply Chain
Figure 64: Generic Drugs Manufacturing: Production Cost Breakup (in %)
Figure 65: Generic Drugs Manufacturing: Detailed Process Flow
Figure 66: Generic Drugs Manufacturing Process: Conversion Rate of Feedstocks
Figure 67: Generic Drugs Manufacturing: Proposed Plant Layout
Figure 68: Generic Drugs Manufacturing Plant: Breakup of Capital Costs (in %)

List of Table

Table 1: Global: Generic Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Generic Drugs Market Forecast: Breakup by Country (in Million US$), 2023-2028
Table 3: Global: Generic Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2023-2028
Table 4: Global: Generic Drugs Market Forecast: Breakup by Drug Delivery (in Million US$), 2023-2028
Table 5: Global: Generic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Generic Drugs Market: Competitive Structure
Table 7: Generic Drugs Market: Key Players
Table 8: Generic Drugs Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 9: Generic Drugs Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 10: Generic Drugs Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 11: Generic Drugs Manufacturing Plant: Raw Material Requirements
Table 12: Generic Drugs Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 13: Generic Drugs Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 14: Details of Financial Assistance Offered by Financial Institutions
Table 15: Generic Drugs Manufacturing Plant: Capital Costs (in US$)
Table 16: Generic Drugs Manufacturing Plant: Techno-Economic Parameters
Table 17: Generic Drugs Manufacturing Plant: Taxation and Depreciation (in US$)
Table 18: Generic Drugs Manufacturing Plant: Income Projections (in US$)
Table 19: Generic Drugs Manufacturing Plant: Expenditure Projections (in US$)
Table 20: Generic Drugs Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$) 
Table 21: Generic Drugs Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 22: Generic Drugs Manufacturing Plant: Profit and Loss Account (in US$)